We are live on ! Find out more
KURA icon

Kura Oncology
KURA

151 hedge funds and large institutions have $897M invested in Kura Oncology in 2021 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 52 increasing their positions, 40 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

119% more call options, than puts

Call options by funds: $11.1M | Put options by funds: $5.08M

30% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 40

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 27

1% less funds holding

Funds holding: 152 → 151 (-1)

4.34% less ownership

Funds ownership: 100.66% → 96.32% (-4.3%)

28% less capital invested

Capital invested by funds: $1.24B → $897M (-$346M)

Holders
151
Holders Change
-1
Holders Change %
-0.66%
% of All Funds
2.32%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
27
Increased
52
Reduced
40
Closed
27
Calls
$11.1M
Puts
$5.08M
Net Calls
+$6.06M
Net Calls Change
+$3.56M

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$19.4M
2
SCM
Suvretta Capital Management
New York
+$18M
3
BI
BVF Inc
California
+$6.95M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$5.47M
5
ACM
Asymmetry Capital Management
California
+$4.99M

Top Sellers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
-$44.8M
2
BC
Boxer Capital
California
-$19.7M
3
Invesco
Invesco
Georgia
-$19.4M
4
CC
Commodore Capital
New York
-$18.7M
5
RSCM
Rock Springs Capital Management
Maryland
-$15.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
CM
51
Caption Management
Oklahoma
$2.2M +$2.54M +157,000 New
Barclays
52
Barclays
United Kingdom
$1.76M +$692K +42,711 +51%
Swiss National Bank
53
Swiss National Bank
Switzerland
$1.74M – – –
DCM
54
DAFNA Capital Management
California
$1.55M +$162K +10,000 +10%
AGA
55
Altrinsic Global Advisors
Connecticut
$1.54M – – –
JP Morgan Chase
56
JP Morgan Chase
New York
$1.49M +$819K +50,547 +91%
RhumbLine Advisers
57
RhumbLine Advisers
Massachusetts
$1.27M -$18.2K -1,124 -1%
PVI
58
Pura Vida Investments
New York
$1.25M +$103K +6,346 +8%
ACM
59
Alethea Capital Management
Washington
$1.2M +$1.39M +85,800 New
IHAM
60
Integral Health Asset Management
New York
$1.19M +$405K +25,000 +42%
State of Wisconsin Investment Board
61
State of Wisconsin Investment Board
Wisconsin
$1.18M – – –
Morgan Stanley
62
Morgan Stanley
New York
$1.17M -$1.26M -77,738 -48%
California State Teachers Retirement System (CalSTRS)
63
California State Teachers Retirement System (CalSTRS)
California
$1.15M +$25.6K +1,581 +2%
HS
64
HighVista Strategies
Massachusetts
$1.15M +$182K +11,236 +16%
AllianceBernstein
65
AllianceBernstein
Tennessee
$1.12M – – –
Federated Hermes
66
Federated Hermes
Pennsylvania
$1.09M +$1.26M +78,083 New
Renaissance Technologies
67
Renaissance Technologies
New York
$948K -$1.72M -106,400 -61%
SCM
68
Silverarc Capital Management
Massachusetts
$935K +$165K +10,198 +18%
EAM
69
Erste Asset Management
Austria
$850K – – –
CSS
70
Cubist Systematic Strategies
Connecticut
$850K -$266K -16,420 -21%
ACM
71
AlphaCrest Capital Management
New York
$829K +$747K +46,081 +352%
Russell Investments Group
72
Russell Investments Group
United Kingdom
$810K +$116K +7,165 +14%
AWA
73
Aaron Wealth Advisors
Illinois
$795K +$2.88K +178 +0.3%
Hudson Bay Capital Management
74
Hudson Bay Capital Management
Connecticut
$793K -$784K -48,368 -46%
LCM
75
Laurion Capital Management
New York
$700K – – –
1 2
3
4 5

KURA Hedge Fund Activity: Q4 2021 in Review

151 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q4 2021, worth a combined $897M — down 28% from $1.24B a quarter earlier.

Fund positioning in KURA was balanced in Q4 2021: 27 funds opened new positions, 27 closed out, 52 added to existing stakes and 40 trimmed.

The largest buyer was Deerfield Management, adding an estimated $19.4M. The largest seller was Ameriprise, exiting entirely with an estimated $44.8M sold.

  • 151 institutional investors held Kura Oncology (KURA) as of Q4 2021, down from 152 in Q3 2021.
  • Funds reported $897M of Kura Oncology stock for Q4 2021, down 28% quarter-over-quarter.
  • 27 funds opened new Kura Oncology positions in Q4 2021 and 27 closed out, a net change of 0 holders.
  • The largest Kura Oncology buyer in Q4 2021 was Deerfield Management, an estimated $19.4M added.
  • The largest Kura Oncology seller in Q4 2021 was Ameriprise, an estimated $44.8M sold.

Based on aggregated 13F filings for Q4 2021.